Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Geographic Atrophy peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Geographic Atrophy. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
1 profiles.
2020–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 25 selected PubMed records and 2 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Geographic Atrophy unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT02503332
PeptideScanner retained ClinicalTrials.gov record NCT02503332 at 2026-11-16T01:37:14.654Z. Its registry update date was 2020-10-06, and PeptideScanner's reviewed identity mapping was pegcetacoplan.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 6, 2020
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03525613
PeptideScanner retained ClinicalTrials.gov record NCT03525613 at 2026-11-16T01:37:14.654Z. Its registry update date was 2023-07-06, and PeptideScanner's reviewed identity mapping was pegcetacoplan.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- July 6, 2023
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06161584
PeptideScanner retained ClinicalTrials.gov record NCT06161584 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-06-01, and PeptideScanner's reviewed identity mapping was pegcetacoplan.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- June 1, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Pegcetacoplan · 2026-11-12
ClinicalTrials.gov record NCT06722157
Completed at the retained observation.
Open attributed record →Pegcetacoplan · 2026-07-13
ClinicalTrials.gov record NCT07160179
Recruiting at the retained observation.
Open attributed record →Pegcetacoplan · 2026-06-01
ClinicalTrials.gov record NCT06161584
Active, not recruiting at the retained observation.
Open attributed record →Pegcetacoplan · 2023-07-06
ClinicalTrials.gov record NCT03525613
Completed at the retained observation.
Open attributed record →Pegcetacoplan · 2020-10-06
ClinicalTrials.gov record NCT02503332
Completed at the retained observation.
Open attributed record →